Latest papers

VEGF blockade decreases the tumor uptake of systemic oncolytic herpes virus but enhances therapeutic efficacy when given after virotherapy.

Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors.

Eradication of brain tumor stem cells with an oncolytic adenovirus.

In vivo biological purging for lymph node metastasis of human colorectal cancer by telomerase-specific oncolytic virotherapy.

Transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1 for targeting prostate tumors.

Oncolytic viruses: now interviewing for the all-star game.

Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity.

Parvovirus H-1 induces cytopathic effects in breast carcinoma-derived cultures.

Verapamil enhances the antitumoral efficacy of oncolytic adenoviruses.

Bovine herpesvirus type 1 as a novel oncolytic virus.

Synergistic interaction between oncolytic viruses augments tumor killing.

Selective targeting of HPV-16 E6/E7 in cervical cancer cells with a potent oncolytic adenovirus and its enhanced effect with radiotherapy in vitro and vivo

[Mechanisms of enhanced antileukemia activity of conditionally replicating adenovirus (CRAd) ZD55 by interleukin-24].

Noninvasive monitoring of mRFP1- and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging.

Enhancing the therapeutic effect against ovarian cancer through a combination of viral oncolysis and antigen-specific immunotherapy.

Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virus.

Crossing the boundaries: stem cells and gene therapy.

Enhanced antitumor effects of an engineered measles virus Edmonston strain expressing the wild-type N, P, L genes on human renal cell carcinoma.

The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins.

Adipose-derived stem cells as therapeutic delivery vehicles of an oncolytic virus for glioblastoma.